Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Preparation method of mixed medicine containing heart-protecting musk pill for preventing and treating angina pectoris and chronic cardiac insufficiency

A technology of coronary heart disease angina pectoris and Shexiang Baoxin pills, applied in the field of traditional Chinese medicine, can solve the problem that it is difficult to effectively reduce the mortality rate and rehospitalization rate of elderly heart failure, the treatment status of heart failure has not been fundamentally improved, and it is difficult to effectively reduce the elderly heart failure. It can stabilize the atherosclerotic plaque, improve clinical symptoms and cardiac function indicators, and reduce the size of myocardial infarction.

Inactive Publication Date: 2014-07-02
田芳
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] For a long time, drugs such as isosorbide dinitrate, metoprolol tartrate, furosemide, and captopril have been used to treat elderly heart failure. Although they have played a great role in the treatment of heart failure, the treatment status of heart failure It has not been fundamentally improved, and the treatment effect is not satisfactory. It is difficult to effectively reduce the mortality rate and rehospitalization rate of elderly heart failure patients. How to improve the quality of life, 5-year survival period and reduce rehospitalization rate of elderly patients with heart failure, and develop new and effective treatments Drugs for heart failure have become a major research topic in the cardiovascular field
[0005] The retrieved application number is 200510109554.6, which discloses a pharmaceutical composition for treating heart failure. It uses red ginseng, sun-burned astragalus, aconite, sun-burned epimedium, salvia miltiorrhiza, Chuanxiong, citrus citrus citrus, Radix Ophiopogon japonicus, and Tinglizi to treat heart failure in the elderly. The failure effect is not obvious, and it is difficult to effectively reduce the mortality rate of heart failure in the elderly

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] The composition weight percentage of each component is: 25-85% of Shexiang Baoxin Pills, 5-15% of Isosorbide Mononitrate Tablets, 6.25-20% of Metoprolol Tartrate Tablets, 6.25-25% of Hydrochlorothiazide Tablets %, spironolactone tablets 5-20%, captopril tablets 12.5-30%, aspirin tablets 10-93%, atorvastatin tablets 15-20%, the sum of the above components by weight is 100%.

Embodiment 2

[0026] The composition weight percentage of each component is: 25-75% of Shexiang Baoxin Pills, 10-14% of Isosorbide Mononitrate Tablets, 7.25-18% of Metoprolol Tartrate Tablets, 12.5-25% of Hydrochlorothiazide Tablets %, 10-20% of spironolactone tablets, 12.5-25% of captopril tablets, 15-90% of aspirin tablets, 16-20% of atorvastatin tablets, the sum of the above components by weight is 100%.

Embodiment 3

[0028] The composition weight percentage of each component is: Shexiang Baoxin Pills 27-85%, Isosorbide Mononitrate Tablets 7-13%, Metoprolol Tartrate Tablets 6.25-18%, Hydrochlorothiazide Tablets 12.5-25% %, 10-20% of spironolactone tablets, 12.5-25% of captopril tablets, 15-87% of aspirin tablets, 15-18% of atorvastatin tablets, the sum of the above components by weight is 100%.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to a preparation method of a mixed medicine containing a heart-protecting musk pill for preventing and treating angina pectoris and chronic cardiac insufficiency. On the basis of conventional therapy, the heart-protecting musk pill is added for treating angina pectoris and chronic cardiac insufficiency, therefore, clinical symptoms and cardiac function indexes of patients are further improved; furthermore, obvious adverse reaction does not exist; the mixed medicine disclosed by the invention is the effective and safe medicine for treating angina pectoris and chronic cardiac insufficiency; the cardiac function is improved by above two stages after treatment; and symptoms and signs are relieved completely or partly.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a compounding method of a mixed drug containing Shexiang Baoxin pills for preventing and treating angina pectoris of coronary heart disease and chronic cardiac insufficiency. Background technique [0002] Heart failure refers to a syndrome of cardiac insufficiency caused by various heart diseases. In most cases, it refers to the decrease of myocardial contractility so that the cardiac output cannot meet the needs of the body's metabolism. Pulmonary circulation and (or) performance of systemic circulation congestion. Heart failure is the terminal stage of various heart diseases. [0003] With the acceleration of the aging population and the increase in the incidence of common cardiovascular diseases such as hypertension and coronary heart disease, the prevalence of heart failure is gradually increasing. According to statistics, the prevalence of heart failure in the po...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/54A61P9/10A61P9/00A61K31/401A61K31/40A61K31/616A61K31/34A61K31/138A61K31/585A61K31/045A61K35/413A61K35/55A61K35/56A61K35/65
Inventor 田芳
Owner 田芳
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com